154 related articles for article (PubMed ID: 11989805)
1. New benzimidazole derivatives as antimycobacterial agents.
Klimesová V; Kocí J; Waisser K; Kaustová J
Farmaco; 2002 Apr; 57(4):259-65. PubMed ID: 11989805
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents.
Klimesová V; Kocí J; Pour M; Stachel J; Waisser K; Kaustová J
Eur J Med Chem; 2002 May; 37(5):409-18. PubMed ID: 12008055
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
4. Quinazoline derivatives with antitubercular activity.
Kunes J; Bazant J; Pour M; Waisser K; Slosárek M; Janota J
Farmaco; 2000; 55(11-12):725-9. PubMed ID: 11204949
[TBL] [Abstract][Full Text] [Related]
5. Effect of substitution on the antimycobacterial activity of 2-(substituted benzyl)sulfanyl benzimidazoles, benzoxazoles, and benzothiazoles--a quantitative structure-activity relationship study.
Pytela O; Klimešová V
Chem Pharm Bull (Tokyo); 2011; 59(2):179-84. PubMed ID: 21297296
[TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Palát K; Kaustová J; Danse HM; Möllmann U
Pharmazie; 2003 Feb; 58(2):83-94. PubMed ID: 12641321
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial activity of pyridylmethylsulfanyl and naphthylmethylsulfanyl derivatives of benzazoles, 1, 2, 4-triazole, and pyridine-2-carbothioamide/-2-carbonitrile.
Zahajská L; Klimesová V; Kocí J; Waisser K; Kaustová J
Arch Pharm (Weinheim); 2004 Oct; 337(10):549-55. PubMed ID: 15476287
[TBL] [Abstract][Full Text] [Related]
8. Relationships between the chemical structure of antimycobacterial substances and their activity against atypical strains. Part 14: 3-Aryl-6,8-dihalogeno-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Hladuvková J; Gregor J; Rada T; Kubicová L; Klimesová V; Kaustová J
Arch Pharm (Weinheim); 1998 Jan; 331(1):3-6. PubMed ID: 9507695
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activities of new bis-benzimidazoles.
Küçükbay H; Durmaz R; Okuyucu N; Günal S; Kazaz C
Arzneimittelforschung; 2004; 54(1):64-8. PubMed ID: 14979611
[TBL] [Abstract][Full Text] [Related]
10. Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
Sirim MM; Krishna VS; Sriram D; Unsal Tan O
Eur J Med Chem; 2020 Feb; 188():112010. PubMed ID: 31893548
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimicrobial screening of N-[2-(2/4-substituted phenyl)-1-(5/6 substituted 1H- benzimidazol-2-yl)vinyl]benzamides.
Kaushik D; Khan SA; Chawla G; Panda BP
Acta Pol Pharm; 2012; 69(4):629-36. PubMed ID: 22876605
[TBL] [Abstract][Full Text] [Related]
12. On the relationship between the substitution pattern of thiobenzanilides and their antimycobacterial activity.
Kunes J; Balsánek V; Pour M; Waisser K; Kaustová J
Farmaco; 2002 Sep; 57(9):777-82. PubMed ID: 12385530
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of New Fluoro-Benzimidazole Derivatives as an Approach towards the Discovery of Novel Intestinal Antiseptic Drug Candidates.
Cevik UA; Saglik BN; Ozkay Y; Canturk Z; Bueno J; Demirci F; Koparal AS
Curr Pharm Des; 2017; 23(15):2276-2286. PubMed ID: 27908268
[TBL] [Abstract][Full Text] [Related]
14. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the antimycobacterial activity of 8-hydroxyquinolines.
Cieslik W; Spaczynska E; Malarz K; Tabak D; Nevin E; O'Mahony J; Coffey A; Mrozek-Wilczkiewicz A; Jampilek J; Musiol R
Med Chem; 2015; 11(8):771-9. PubMed ID: 26256587
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of positional isomers of 5 and 6-bromo-1-[(phenyl)sulfonyl]-2-[(4-nitrophenoxy)methyl]-1H-benzimidazoles as possible antimicrobial and antitubercular agents.
Ranjith PK; Rajeesh P; Haridas KR; Susanta NK; Row TN; Rishikesan R; Kumari NS
Bioorg Med Chem Lett; 2013 Sep; 23(18):5228-34. PubMed ID: 23942420
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.
Klimesová V; Zahajská L; Waisser K; Kaustová J; Möllmann U
Farmaco; 2004 Apr; 59(4):279-88. PubMed ID: 15081345
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial activity of new ortho-, meta- and para-toluidine derivatives.
Biava M; Fioravanti R; Porretta GC; Sleiter G; Deidda D; Lampis G; Pompei R
Farmaco; 1999; 54(11-12):721-7. PubMed ID: 10668170
[TBL] [Abstract][Full Text] [Related]
20. New pyridine derivatives as potential antimicrobial agents.
Klimesová V; Svoboda M; Waisser K; Pour M; Kaustová J
Farmaco; 1999 Oct; 54(10):666-72. PubMed ID: 10575735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
